Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) FCF Margin (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed FCF Margin for 3 consecutive years, with 35.2% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 1345.0% to 35.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.76% through Dec 2025, down 1050.0% year-over-year, with the annual reading at 3.76% for FY2025, 1050.0% down from the prior year.
  • FCF Margin hit 35.2% in Q4 2025 for Immunocore Holdings, down from 3.82% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 30.69% in Q2 2024 to a low of 35.2% in Q4 2025.
  • Historically, FCF Margin has averaged 1.3% across 3 years, with a median of 1.06% in 2023.
  • Biggest five-year swings in FCF Margin: soared 3295bps in 2024 and later tumbled -3005bps in 2025.
  • Year by year, FCF Margin stood at 26.44% in 2023, then rose by 18bps to 21.75% in 2024, then tumbled by -62bps to 35.2% in 2025.
  • Business Quant data shows FCF Margin for IMCR at 35.2% in Q4 2025, 3.82% in Q3 2025, and 26.08% in Q2 2025.